Dogma supports NLRP3-induced inflammation as fundamental to changes in glucose tolerance, insulin resistance and inflammation as observed in both type 1 (T1DM) and type 2 diabetes mellitus (T2DM) (Ding et al., 2019). Here, NLRP3 is linked to type 1 diabetes mellitus.